GEODE CAPITAL MANAGEMENT, LLC
Position in APUS — Apimeds Pharmaceuticals US, Inc.
CIK 1214717
BOSTON, MA
Position in APUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$71,650
-$500,513 QoQ
Shares Held
40,051
+14.8% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 6 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APUS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,630,059,403 across 67 Drug Manufacturers - Specialty & Generic names. APUS ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
11,349,248 | $1,341,594,605 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,233,029 | $731,161,535 | |
| 3 | VTRS |
Viatris Inc
|
31,846,107 | $430,240,905 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,564,988 | $318,217,437 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,136,672 | $281,485,168 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,192,404 | $267,834,227 | |
| 7 | ALKS |
Alkermes plc.
|
4,182,267 | $147,884,960 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,765,952 | $133,947,458 |
All Filings in APUS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71,650 | 40,051 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $572,163 | 34,888 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $547,420 | 30,754 | Shares | Defined | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||